Skip to main content

Advertisement

Log in

Depressive symptoms during the first chemotherapy cycle predict mortality in patients with advanced non-small cell lung cancer

  • Original Article
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

Abstract

Purpose

Depressive symptoms are commonly experienced by cancer patients, especially those with advanced disease. The link between depression and survival outcome in cancer patients has received increasing attention. The purpose of this study was to determine, after adjusting the known covariates, whether the depressive symptoms during the first cycle of chemotherapy can predict the mortality of patients with advanced non-small cell lung cancer (NSCLC).

Methods

Patients with stage III or IV NSCLC were recruited from a large teaching hospital located in northern Taiwan. Depressive symptoms were assessed during the first cycle of chemotherapy using the Hospital Anxiety and Depression Scale-Depression subscale. A cut-off of 7/8 was used to categorize patients into depressed and non-depressed groups. All patients were followed up until the end of the study. The follow-up time ranged from 10 to 30 months.

Results

The study sample consisted of 90 NSCLC patients. Twenty patients (22.2%) were categorized as depressed. The median survival time in the depressed group was significantly shorter than that of the non-depressed group (11.83 vs. 24.47 months, P = 0.017). After controlling for demographic and clinical factors, depressive symptoms remained significantly (p = 0.023) associated with a shorter survival time. Compared to the non-depressed group, the depressed group had twice the risk of death (HR = 2.18, 95% CI = 1.11 to 4.28).

Conclusion

The finding supports that depressive symptoms at the early phase of treatment can predict shorter survival in patients with advanced NSCLC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. (2009) Cancer Registration Annual Report 2006. Bureau of Health Promotion, Department of Health, The Executive Yuan, Taiwan, Taipei

  2. Gotay CC, Kawamoto CT, Bottomley A, Efficace F (2008) The prognostic significance of patient-reported outcomes in cancer clinical trials. J Clin Oncol 26:1355–1363

    Article  PubMed  Google Scholar 

  3. Zabora J, BrintzenhofeSzoc K, Curbow B, Hooker C, Piantadosi S (2001) The prevalence of psychological distress by cancer site. Psychooncology 10:19–28

    Article  PubMed  CAS  Google Scholar 

  4. Hopwood P, Stephens RJ (2000) Depression in patients with lung cancer: prevalence and risk factors derived from quality-of-life data. J Clin Oncol 18:893–903

    PubMed  CAS  Google Scholar 

  5. Spiegel D, Giese-Davis J (2003) Depression and cancer: mechanisms and disease progression. Biol Psychiatry 54:269–282

    Article  PubMed  Google Scholar 

  6. Satin JR, Linden W, Phillips MJ (2009) Depression as a predictor of disease progression and mortality in cancer patients: a meta-analysis. Cancer 115:5349–5361

    Article  PubMed  Google Scholar 

  7. Onitilo AA, Nietert PJ, Egede LE (2006) Effect of depression on all-cause mortality in adults with cancer and differential effects by cancer site. Gen Hosp Psychiatry 28:396–402

    Article  PubMed  Google Scholar 

  8. Buccheri G (1998) Depressive reactions to lung cancer are common and often followed by a poor outcome. Eur Respir J 11:173–178

    Article  PubMed  CAS  Google Scholar 

  9. Pirl WF, Temel JS, Billings A, Dahlin C, Jackson V, Prigerson HG, Greer J, Lynch TJ (2008) Depression after diagnosis of advanced non-small cell lung cancer and survival: a pilot study. Psychosomatics 49:218–224

    Article  PubMed  Google Scholar 

  10. Akechi T, Okamura H, Okuyama T, Furukawa TA, Nishiwaki Y, Uchitomi Y (2009) Psychosocial factors and survival after diagnosis of inoperable non-small cell lung cancer. Psychooncology 18:23–29

    Article  PubMed  Google Scholar 

  11. Faller H, Bulzebruck H, Drings P, Lang H (1999) Coping, distress, and survival among patients with lung cancer. Arch Gen Psychiatry 56:756–762

    Article  PubMed  CAS  Google Scholar 

  12. Faller H, Schmidt M (2004) Prognostic value of depressive coping and depression in survival of lung cancer patients. Psychooncology 13:359–363

    Article  PubMed  Google Scholar 

  13. Nakaya N, Saito-Nakaya K, Akechi T, Kuriyama S, Inagaki M, Kikuchi N, Nagai K, Tsugane S, Nishiwaki Y, Tsuji I, Uchitomi Y (2008) Negative psychological aspects and survival in lung cancer patients. Psychooncology 17:466–473

    Article  PubMed  Google Scholar 

  14. Nakaya N, Saito-Nakaya K, Akizuki N, Yoshikawa E, Kobayakawa M, Fujimori M, Nagai K, Nishiwaki Y, Fukudo S, Tsubono Y, Uchitomi Y (2006) Depression and survival in patients with non-small cell lung cancer after curative resection: a preliminary study. Cancer Sci 97:199–205

    Article  PubMed  CAS  Google Scholar 

  15. Peck A (1972) Emotional reactions to having cancer. CA Cancer J Clin 22:284–291

    Article  PubMed  CAS  Google Scholar 

  16. Folstein MF, Folstein SE, McHugh PR (1975) “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198

    Article  PubMed  CAS  Google Scholar 

  17. Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67:361–370

    Article  PubMed  CAS  Google Scholar 

  18. Herrmann C (1997) International experiences with the Hospital Anxiety and Depression Scale—a review of validation data and clinical results. J Psychosom Res 42:17–41

    Article  PubMed  CAS  Google Scholar 

  19. Chen ML, Chang HK, Yeh CH (2000) Anxiety and depression in Taiwanese cancer patients with and without pain. J Adv Nurs 32:944–951

    PubMed  CAS  Google Scholar 

  20. Chen ML, Tseng HC (2006) Symptom clusters in cancer patients. Support Care Cancer 14:825–830

    Article  PubMed  Google Scholar 

  21. Lien CY, Lin HR, Kuo IT, Chen ML (2009) Perceived uncertainty, social support and psychological adjustment in older patients with cancer being treated with surgery. J Clin Nurs 18:2311–2319

    Article  PubMed  Google Scholar 

  22. Karnofsky DA, Burchenal JH (1949) The clinical evaluation of chemotherapeutic agents. In: MacLeod CM (ed) Evaluation of chemotherapeutic agents. Columbia University Press, New York, pp 191–205

    Google Scholar 

  23. Stommel M, Given BA, Given CW (2002) Depression and functional status as predictors of death among cancer patients. Cancer 94:2719–2727

    Article  PubMed  Google Scholar 

  24. Hjerl K, Andersen EW, Keiding N, Mouridsen HT, Mortensen PB, Jorgensen T (2003) Depression as a prognostic factor for breast cancer mortality. Psychosomatics 44:24–30

    Article  PubMed  Google Scholar 

  25. Eton DT, Fairclough DL, Cella D, Yount SE, Bonomi P, Johnson DH (2003) Early change in patient-reported health during lung cancer chemotherapy predicts clinical outcomes beyond those predicted by baseline report: results from Eastern Cooperative Oncology Group Study 5592. J Clin Oncol 21:1536–1543

    Article  PubMed  Google Scholar 

  26. Wang XS, Shi Q, Lu C, Basch EM, Johnson VE, Mendoza TR, Mobley GM, Cleeland CS (2010) Prognostic value of symptom burden for overall survival in patients receiving chemotherapy for advanced nonsmall cell lung cancer. Cancer 116:137–145

    PubMed  Google Scholar 

  27. Motulsky H (1995) Intuitive biostatistics. Oxford University Press, New York

    Google Scholar 

  28. Peduzzi P, Concato J, Feinstein AR, Holford TR (1995) Importance of events per independent variable in proportional hazards regression analysis II: accuracy and precision of regression estimates. J Clin Epidemiol 48:1503–1510

    Article  PubMed  CAS  Google Scholar 

  29. Castelli L, Binaschi L, Caldera P, Torta R (2009) Depression in lung cancer patients: is the HADS an effective screening tool? Support Care Cancer 17:1129–1132

    Article  Google Scholar 

  30. Walker MS, Zona DM, Fisher EB (2006) Depressive symptoms after lung cancer surgery: their relation to coping style and social support. Psychooncology 15:684–693

    Article  PubMed  Google Scholar 

Download references

Acknowledgement

This study was supported by research grants to Dr. Mei-Ling Chen from the National Science Council, Taiwan (grant numbers: NSC 94-2314-B-182-055, NSC 95-2314-B-182-012, and NSC 96-2314-B-182-006).

Conflict of interest

There is no relevant conflict of interest in this manuscript. We have full control of all primary data which can be reviewed by the journal if required.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mei-Ling Chen.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chen, ML., Chen, MC. & Yu, CT. Depressive symptoms during the first chemotherapy cycle predict mortality in patients with advanced non-small cell lung cancer. Support Care Cancer 19, 1705–1711 (2011). https://doi.org/10.1007/s00520-010-1005-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-010-1005-8

Keywords

Navigation